Fondaparinux-related thrombocytopenia in a patient with former HIT. Response to Rota et al. (Thromb Haemost 2008; 99: 779-781).
Schindewolf
Marc
M
Lindhoff-Last
Edelgard
E
D000906:Antibodies / Q000097:blood; D000925:Anticoagulants / Q000009:adverse effects* / Q000276:immunology; D000077425:Fondaparinux; D006493:Heparin / Q000009:adverse effects* / Q000276:immunology; D006801:Humans; D010976:Platelet Count; D010978:Platelet Factor 4 / Q000276:immunology; D011134:Polysaccharides / Q000009:adverse effects*; D013921:Thrombocytopenia / Q000097:blood / Q000139:chemically induced* / Q000276:immunology; D020246:Venous Thrombosis / Q000517:prevention & control*
D000906:Antibodies; D000925:Anticoagulants; D011134:Polysaccharides; D010978:Platelet Factor 4; D006493:Heparin; D000077425:Fondaparinux